D Hike Promised In Norway

OSLO—Last year’s slump in oil prices not only ended a heady period of growth for Norway’s economy, but it also plunged the nation into its worst fiscal crisis in decades. Despite these problems, the government’s firm belief in the value of technological development has led to a promise to increase R&D spending significantly over the next five years. Norway’s continued commitment to science is made possible in part by its having prepared during the recent boom ye

Written byTony Samstag
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

OSLO—Last year’s slump in oil prices not only ended a heady period of growth for Norway’s economy, but it also plunged the nation into its worst fiscal crisis in decades. Despite these problems, the government’s firm belief in the value of technological development has led to a promise to increase R&D spending significantly over the next five years.

Norway’s continued commitment to science is made possible in part by its having prepared during the recent boom years for the inevitable downturn. Previous collapses, for example, of its herring industry and its northern forests have taught politicians the value of tsking a long-range view of economic development.

It was not surprising, then, that a government booklet extolling the technological triumphs of Norwegian industry appeared within weeks of the start of the present crisis. Its 50 pages were filled with success stories in such fields as metallic alloys, offshore oil exploration, robotics, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies